Encouraging real-world evidence supports the safety and efficacy of ruxolitinib cream for adults with nonsegmental vitiligo (NSV).1 Published in the International Journal of Dermatology, the study showed that 15 mg/g of the topical formulation of the... [3780 chars].. reed more
